2009
DOI: 10.1002/ange.200804583
|View full text |Cite
|
Sign up to set email alerts
|

A Selective Inhibitor Gal‐PUGNAc of Human Lysosomal β‐Hexosaminidases Modulates Levels of the Ganglioside GM2 in Neuroblastoma Cells

Abstract: Der hoch selektive Inhibitor Gal‐PUGNAc (siehe Bild) für die β‐Hexosaminidasen HEXA und HEXB ist zellgängig und moduliert die Aktivität von HEXA und HEXB in Gewebekulturen in einer Weise, dass die Spiegel des Gangliosids GM2 erhöht werden. Gal‐PUGNAc sollte es ermöglichen, die Rolle dieser Enzyme auf der Zellebene zu analysieren, ohne dass durch gleichzeitige Inhibition der O‐GlcNAcase ein chemisch komplexer Phänotyp entsteht.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
16
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 27 publications
0
16
0
1
Order By: Relevance
“…The analysis of CTD110.6 immunoreactivity pattern against the proteins of these skinned fibers clearly demonstrated that the modification in the calcium activation parameters was associated with an increase of O-GlcNAcylation on predominant proteins expressed in soleus skinned fibers. Recent data demonstrated that PUGNAc could have an effect by inhibiting lysosomal hexosaminidase [36], [37]. Since no complex glycans were detected on proteins extracted from skinned biopsies, we concluded that the only effect of PUGNAc on skinned fibers (and included in T/pCa experiments) was the increase of O-GlcNAc level.…”
Section: Discussionmentioning
confidence: 74%
“…The analysis of CTD110.6 immunoreactivity pattern against the proteins of these skinned fibers clearly demonstrated that the modification in the calcium activation parameters was associated with an increase of O-GlcNAcylation on predominant proteins expressed in soleus skinned fibers. Recent data demonstrated that PUGNAc could have an effect by inhibiting lysosomal hexosaminidase [36], [37]. Since no complex glycans were detected on proteins extracted from skinned biopsies, we concluded that the only effect of PUGNAc on skinned fibers (and included in T/pCa experiments) was the increase of O-GlcNAc level.…”
Section: Discussionmentioning
confidence: 74%
“…In addition to results from in vitro studies, researchers found that increased levels of O-GlcNAcylation lead to insulin resistance in vivo [2,20]. PUGNAc is a potent inhibitor of OGA; however, it has some off-target effects [21,22]. Several papers show that other OGA inhibitors, such as NButGT, do not affect insulin signalling [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…Together, these mechanistic and structural studies have guided the development of potent and specific inhibitors against β-hexosaminidases, 14 , 16 , 18 20 which have acted as powerful tools for probing the cellular function of the enzymes and the roles they play in disease. 21 24 …”
mentioning
confidence: 99%